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Abstract  1 
The development of cascading bio-refinery processes that are capable of producing a range of 2 
valuable products is of increasing significance and will help to ensure that mankind makes 3 
efficient usage of bioresources. Seaweed feedstocks have the potential to be refined into 4 
fractions used for biofuel production, as renewable sources of platform chemicals or for a 5 
range of potentially interesting bioactive compounds. This study describes the development 6 
of a putative bio-refinery approach using Laminaria digitata as feedstock. Firstly, the 7 
commercially valuable polysaccharides fucoidan and alginate were extracted. Analysis of the 8 
monosaccharide and sulphate contents of the fucoidan extract confirmed its isolation with a 9 
purity of ca. 65%. Analysis of the composite residue remaining after extraction of alginate 10 
and fucoidan from  L. digitata showed an increase in crude fibre content, of which the 11 
predominant monosaccharide was glucose (161.9 mg glucose per g residue), making this 12 
residue a potential feedstock for bioethanol production. After dilute acid hydrothermal pre-13 
treatment (1.5 N H2SO4, 24 min, 121°C, 25% [biomass / reactant] solids loading) and 14 
enzymatic saccharification of this residue, a 93.8% of theoretical glucose yield was achieved. 15 
This hydrolysate was fermented using Saccharomyces cerevisiae NCYC2592 and a yield of 16 
ca. 94.4% of the theoretical ethanol yield was achieved. To add value to the biorefining 17 
process, waste streams from the production of alginate, fucoidan and bioethanol were 18 
collected and screened for a range of bioactivities. Subsequently, a methanol extract prepared 19 
from the liquor waste stream which remained after polysaccharide extraction was shown to 20 
exhibit both anti-oxidant (EC50 15.3 mg/mL) and anti-microbial activity against the human 21 
bacterial pathogen Burkholderia cenocepacia. The identification of extracts with bioactive 22 
attributes which have been recovered from a seaweed-based bio-refinery process is novel, 23 
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and offers a potential route through which added value can be derived from natural resources 24 
such as L. digitata.  25 
 26 
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1 Introduction 41 
Seaweeds have gained much attention in recent years as alternative renewable feedstocks due 42 
to their large biomass yields, fast growth rates and the fact that they require no terrestrial land 43 
for cultivation (1). However, many production processes of chemicals from seaweeds have 44 
focussed on a single product, for example alginic acid, carrageenan or even colourants, with 45 
the rest of the seaweed treated as a waste material (2). Furthermore, many current seaweed 46 
research programmes also focus on a single product objective, with much current research 47 
focus on biofuels (3, 4). As an alternative to developing processes based on single products 48 
from seaweeds, cascading bio-refineries are being sought in order to maximise the inherent 49 
value of all components present in the biomass (2, 5-7). Seaweeds are excellent feedstocks 50 
for such bio-refineries as they contain both high value components (such as speciality 51 
polysaccharides and bioactive molecules) and compounds which are considered to be 52 
platform chemicals for the bio-based economy such as glucose (2).  53 
A number of seaweed bio-refinery processes have already been investigated for the 54 
production of biofuels and commodity compounds (e.g. see Kumar et al (8)). Following the 55 
extraction of agar from the red seaweed species Gracilaria verrucosa the residual pulp was 56 
converted into bioethanol; achieving an ethanol yield of 0.43g/g of sugar. Trivedi et al (9) 57 
developed an integrated process which was applied to the green seaweed Ulva fascita that 58 
sequentially recovered a mineral rich liquid extract, lipids, ulvan and cellulose; four fractions 59 
of economic importance. Additionally, various nutrients, pigments (8) and even seaweed salts 60 
(10) could also be extracted from seaweeds, thus increasing the potential value of bio-refining 61 
processes. van der Wal et al [13] generated not only bioethanol but also acetone and butanol 62 
from a hydrolysate derived from green seaweed Ulva lactuca using Clostridium beijerinckii 63 
and Clostridium acetobuticum. This was achieved by solubilising over 90% of the sugars 64 
found in the green seaweed into a fermentable solution (11). However, solubilisation of all 65 
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functional seaweed polysaccharides for biofuel conversion may in the long term jeopardise 66 
the seaweed hydrocolloid industry (12). In 2016 commercial seaweed market was estimated 67 
to be valued at $11.34 billion (http://www.marketsandmarkets.com/Market-68 
Reports/commercial-seaweed-market-152763701.html). The seaweed hydrocolloid market 69 
was estimated to be valued at $1.1 billion (13), compared to bioethanol which at the time of 70 
writing this article was valued at $23.2 million (Renewable Fuels Association; 71 
http://www.ethanolrfa.org/). Therefore the fractionation and selective utilisation of biofuel 72 
substrates, such as the laminarin fraction from seaweed biomass (which is a less utilised 73 
material) for the production of biofuels, would prevent negative impacts on the present 74 
hydrocolloid industry and associated worldwide markets. Additionally, the net worth of a 75 
seaweed bio-refinery for fuels and platform chemicals would also increase.  76 
Brown seaweeds are amenable to bio-refinery processing as they contain a diverse array of 77 
metabolites with existing or potential applications. These include extracellular matrix 78 
polysaccharides such as alginates and fucoidans, storage polysaccharides such as laminarin 79 
and mannitol and bio-active polyphenolic compounds and pigments such as fucoxanthin (14). 80 
Such species have been mainly exploited for the anionic polysaccharide alginate that is 81 
widely used in the pharmaceutical, food, cosmetic and biotechnology industries due to its 82 
favourable gelling properties (15). The interest in new sources of natural bioactives such as 83 
antioxidants and antimicrobials has increased in recent years. One reason for this has been a 84 
desire to reduce the use of synthetic forms of antioxidants and antimicrobials such as 85 
butylated hydrolxytoluene (BHT) and propyl gallate (PG) where strict regulations have been 86 
applied due to their potential health hazards. In recent years sulphated polysaccharides such 87 
as fucoidan have received attention (16) due to their specific biological activities and 88 
properties such as anti-inflammatory (17), anti-tumor (18) and anti-coagulant (19).  89 
 90 
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Bio-refinery processes using different species of brown seaweeds, including Saccharina 91 
latissimi and Ascophyllum nodosum have been explored for mannitol isolation (20) and 92 
fucoidan, alginate, sugars and biochar production (7), respectively. In addition, bio-refinery 93 
scenarios were investigated with Laminaria digitata where bioethanol (21) and succinic acid 94 
(22) were produced and the remaining residues analysed as potential feedstocks for biogas 95 
production, biodiesel, and feed supplements (due to enriched protein and fatty acid fractions).  96 
The kelp Laminaria digitata (Hudson) J.V. Lamouroux is found in North Atlantic waters and 97 
is one of the most prevalent species of brown seaweed found around the UK coastline (23). It 98 
is one of the largest growing species within the brown taxonomic group and large scale 99 
mechanical harvesting of this species takes place in Brittany, France and Iceland (1). On 100 
average, approximately 60,000 tonnes (wet weight) of the seaweed is harvested annually in 101 
France (24); making it a suitable feedstock for the development of bio-refinery processes in 102 
Europe.  103 
The present study describes the development of a putative integrated bio-refinery process 104 
using L. digitata, based around the extraction of the commercially valuable phycocolloids 105 
alginate and fucoidan, the subsequent production of bioethanol and also the identification of 106 
potential bioactive compounds in the waste stream liquors produced. This study was not 107 
intended to represent a fully optimised process, but rather to evaluate the potential of using 108 
this species of brown seaweed as a feedstock and to establish prospective processing routes 109 
that could form the basis of a L. digitata bio-refinery.  110 
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2 Materials and Methods 111 
2.1 Reagents 112 
All reagents were of AnalAR grade and obtained from Sigma-Aldrich (UK) and Fisher 113 
Scientific (UK) unless otherwise specified. All water used was subjected to deionised (DI) 114 
reverse osmosis and of ≥18 mega-ohm purity. 115 
2.2 Seaweed collection and preparation 116 
The seaweed used in this study (L. digitata) was collected at spring low tides in May 2013 117 
near Downderry in Cornwall (GPS coordinates: 50.3623° N. 4.3687° W). The seaweed was 118 
rinsed in distilled water to remove salt and debris, and then dried in a fan oven at 80 °C for a 119 
minimum of 48 h until perceived to be dry. The dried seaweed was then milled using a ball 120 
mill (Fritsch, Germany) to obtain a fine homogeneous powder and stored in a desiccator 121 
away from direct sunlight and moisture until further analysis. 122 
2.3 Fucoidan (and alginate) extraction 123 
A schematic of the overall bio-refinery process is summarised in Fig 1. 124 
 125 
8 
 
Fig 1 Schematic diagram of the bio-refining process developed for L. digitata for the 126 
extraction of value added compounds in addition to bioethanol and residues/waste streams 127 
with potential bioactivity. 128 
Fucoidan was extracted following the method outlined by Black at et (25). L. digitata (2 g) 129 
was mixed with 20 mL of 0.1 M HCl (pH 2-2.5) at 70°C for 1 h. The mixture was stirred at 130 
250 rpm and then centrifuged at 5000 rpm for 15 min to separate the liquid from the seaweed 131 
solids. One volume of 1% (w/v) CaCl2 was added to the recovered liquid, inverted and kept at 132 
4°C for 72 h. The precipitate which formed (alginate) was removed from the liquid phase by 133 
centrifugation at 5000 rpm for 20 mins, freeze dried and lastly weighed. Two volumes of 134 
absolute ethanol (99.99%) were then added to the remaining alginate-free liquor, inverted and 135 
kept at 4°C for 24 h. The precipitate was recovered by centrifugation at 5000 rpm for 20 min 136 
and the upper liquid phase (waste liquor) was stored at -4°C until further analysis. The solid 137 
precipitate (fucoidan) was freeze-dried and stored at -80°C until further analysis. Seaweed 138 
solids (waste residue) which remained after the extraction were dried in an oven at 60°C until 139 
all water had evaporated and stored in an airtight container until further analysis.  140 
2.4 Composition analysis of native L. digitata biomass and waste residue generated 141 
after extraction 142 
Native L. digitata and L. digitata waste residue generated from the process (the new 143 
composite material from section 2.3) were analysed for moisture, ash, protein (total N × 6.25 144 
conversion factor), lipid, crude fibre and carbohydrate contents. This analysis was conducted 145 
externally by Eurofins Food Testing Ltd, UK.  146 
Monosaccharide analysis of the L. digitata residue was determined by the method outlined by 147 
Kostas et al (26) where 1 mL of 11 M H2SO4 was added to 30 mg of seaweed in a heat 148 
resistant screw cap glass tube and incubated at 37˚C for 1 h. Water (11 mL) was added to the 149 
sample to dilute the acid strength to 1 M, following which, samples were incubated at 100˚C 150 
9 
 
for 2 h. Liberated monosaccharides (mannitol, fucose, arabinose, galactose, glucose and 151 
xylose) were analysed by HPAEC-PAD as described in section 2.8.    152 
2.5 Characterisation of fucoidan extract 153 
2.5.1 Fucoidan extract quantification and determination of purity 154 
Solutions of fucoidan extracts (10 g/L) were prepared with RO water. The samples were then 155 
run on a HPLC using an AS-2055 Intelligent Auto-sampler and a PU-1580 Intelligent HPLC 156 
Pump (Jasco, Japan). The Rezex ROA Organic Acid H+ organic acid column (5 μm, 7.8 157 
mm×300 mm; Phenomenex, UK) was operated at ambient temperature with a mobile phase 158 
of 0.005 N H2SO4 at a flow rate of 0.5 mL min
−1
. A Refractive Index cell (RI-2031 Intelligent 159 
Refractive Index detector, Jasco, Japan) was used for detection, and the injection volume was 160 
10 μL. Data were acquired using the Azur software package v. 4.6.0.0 (Datalys, France). 161 
Prior to HPLC analysis, all samples and standards were filtered using Whatman GD/X 162 
syringe filters (GF/C 25 mm filter diameter/1.2 μm pore size; Whatman, UK). Authentic 163 
standards of fucoidan (Sigma-Aldrich
®
, USA) with concentrations within range of 10 g/L to 164 
0.5 g/L were used for quantification.  165 
2.5.2 Monosaccharide profile 166 
The monosaccharide profile of the extracted fucoidan was obtained by following the method 167 
of Rodriguez-Jasso et al (27). Fucoidan extract (10 mg) was hydrolysed with 2 M 168 
Trifluoroacetic acid (0.5 mL) at 121°C for 2 h in N2 sealed heat resistant screw cap glass 169 
tubes. The tubes were then cooled in an iced water bath before being centrifuged at 5000 rpm 170 
for 5 min. Samples were then prepared for monosaccharide quantification using the HPAEC-171 
PAD method described in Section 2.8.   172 
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2.5.3 Sulphate content 173 
The sulphate group content of the extracted fucoidan was determined using a sulphate assay 174 
kit (Sigma-Aldrich
®, USA) according to manufacturer’s instructions. Proprietary reagents 175 
were mixed to induce a concentration dependant colour change which was read at 600 nm 176 
using a Jenway Spectrophotometer. Quantification was performed by comparison to 177 
proprietary standards of barium sulphate (Sigma-Aldrich
®
, USA) over a range of 178 
concentrations (0, 0.5, 1.0, 2.0 mM). 179 
2.6 Bioactivity screening on selected fractions from the bio-refinery process 180 
2.6.1 Extract preparation 181 
Native seaweed (code: L. digitata), the waste residue following extraction of fucoidan and 182 
alginate (code: waste residue), waste liquor from the process (code: waste liquor), the 183 
fucoidan extract (code: fucoidan extract) and a standard of fucoidan from Sigma Aldrich 184 
(code: fucoidan standard) were investigated for selected bioactivity analysis. Extracts from 185 
the bioprocess fractions listed above were individually prepared in either methanol and/or 186 
water (in triplicate). This was done in order to investigate whether extracting in methanol or 187 
water may show any differences in the biological activities of these extracts.    188 
The waste liquor from the process was initially prepared by rotary evaporation at 40°C under 189 
vacuum to remove ethanol. This left behind a dark yellow viscous oil which was then freeze 190 
dried. Glass beads (100 mg, 1.0 mm in diameter) were added to ca 20 mg of 191 
biomass/residue/freeze dried waste liquor in an Eppendorf tube followed by the addition of 1 192 
mL of cold methanol (100%) or water. The samples were placed in a tissue lyser (Qiagen 193 
TissueLyser II, USA) for 10 min at 30 Hz and then centrifuged at 14,000 rpm for 1 min. The 194 
supernatant was decanted into an evaporation tube and stored on ice. A further 1 mL of 195 
methanol or water was added to the Eppendorf tube and the process was repeated one more 196 
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time, pooling together the relevant supernatants. In order to concentrate the extract, the 197 
solvents were evaporated and then the residue re-suspended in a reduced volume (1 mL) of 198 
either methanol and/or water. Extracts were then stored in amber vials at -80°C until further 199 
use. Fucoidan extracts were only prepared using water due to their insolubility in methanol. 200 
2.6.2 Determination of antioxidant activity  201 
2.6.2.1 DPPH● scavenging capacity assay 202 
A 200 μM solution of DPPH was prepared in methanol (100%). For the assays, 100 μL of 203 
DPPH (200 μM) solution was mixed with 100 μL of extract and incubated in the dark at 30°C 204 
for 30 min. The reduction of the DPPH
● 
radical was measured by continuous monitoring of 205 
decolourisation at 518 nm. The control solutions contained 100 μL of distilled water or 100 206 
μL methanol (100%). DPPH● percent of inhibition was calculated according to the following 207 
equation:  208 
𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 (%) =  [(1 − 𝐴sample_518/Acontrol_518)] ∗ 100 
EC50 values were also calculated which indicates the concentration of sample required to 209 
scavenge 50% DPPH radicals, according to the following equation: 210 
EC50 = [
sample concentration (mg/ml)
DPPH inhibition (%)
] × 50 211 
2.6.2.2 ABTS●+ scavenging capacity assay 212 
The ABTS
●+ 
assay was carried out according to the protocol outlined in the work of 213 
Martinez-Avila et al (2012). In order to generate the radical (ABTS
●+
), 12.5 mL of potassium 214 
persulfate (2.45 mM) was mixed with 25 mL of ABTS (7 mM). The mixture was maintained 215 
in the dark at room temperature for 12-16 h. The absorbance was measured at 734 nm and the 216 
ABTS
●+ 
solution was then diluted with ethanol until an absorbance value of 0.7 ± 0.01 was 217 
achieved. For the assays, 950 μL of ABTS●+ solution was added to 50 μL of extract and the 218 
12 
 
absorbance was measured after 1 min of the reaction. The control solutions contained 50 μL 219 
of distilled water or 50 μL methanol (100%). ABTS●+ percent of inhibition was calculated 220 
according to the following equation: 221 
𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 (%) =  [(1 − 𝐴sample_734/Acontrol_734)] × 100 
The radical-scavenging capacity of each sample was calculated according to a Trolox 222 
standard curve (0 to 50 μM in 5 μM increments) and expressed as Trolox equivalent 223 
antioxidant capacity (TEAC) by the extrapolation of ABTS
●+ 
percent inhibition of each tested 224 
sample. Assays were conducted in triplicate. 225 
2.6.3 Determination of antimicrobial activity 226 
2.6.3.1 Preparation of bacterial broths, agar plates and culturing of bacterial strains 227 
Seven human pathogenic strains, one food spoilage pathogen and 3 fish pathogenic strains 228 
were investigated in this study (Table 1).  229 
 230 
 231 
 232 
 233 
 234 
 235 
Table 1 List of pathogens included in this study. Human pathogenic
(a)
, food spoilage
(b)
 and 236 
fish pathogenic
(c)
 bacteria. 237 
 238 
Strains Pathogen Type 
Staphylococcus aureus
a 
Human pathogen 
Salmonella enterica
a 
Human pathogen 
Burkholderia cenocepacia
a 
Human pathogen 
Burkholderia multivorans
a 
Human pathogen 
Bacillus cereus
b 
Food Spoilage Pathogen 
Streptococcus pyogenes
a 
Human pathogen 
Acinetobacter iwofii
a 
Human pathogen 
Listeria monocytogenes
a 
Human pathogen 
Yersinia ruckerii
c 
Fish pathogen 
Vibrio anguillerium
c 
Fish pathogen 
Aeromonas hydrolphila
c 
Fish pathogen 
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The strains were harvested from local waters around the Plymouth shoreline. Two types of 239 
bacterial broth and agar plates were made depending upon bacterial strain. Luria-Bertani 240 
broth (for human pathogenic strains): 5 g bactopeptone, 1 g yeast extract made up to 1L with 241 
DI water. Marine LB broth (for marine pathogens):  5 g bactopeptone, 1 g yeast extract made 242 
up to 1L with filtered sea water. Yeast peptone dextrose (YPD) plates were made following 243 
the same recipe as mentioned above for both pathogen types, however contained 2 g agar. 244 
The bacterial strains were taken from glycerol stocks stored at -80°C and spread onto 245 
appropriate YPD plates and kept at 26°C for 24 h. A loop-full of cells were then inoculated 246 
into 3 mL of LB/marine LB broth. Cultures were placed in a shaking incubator at 26°C for 24 247 
h at 130 rpm.  248 
2.6.3.2 Agar disc diffusion assay 249 
Cells (taken from section 2.6.3.1) were subsequently diluted 1/100 into 25 mL of LB/marine 250 
LB agar and the molten agar was poured into a sterile petri dish. Sterile Whatmann discs (10 251 
mm diameter) were gently placed onto the dish. An aliquot of extract (20 μL) was inoculated 252 
onto the disc and plates were then incubated for 24 h at 30°C. Zones of clearance around each 253 
disc were indicative of antimicrobial activity and were examined by eye. Each extract was 254 
tested in triplicate and water and methanol were included in this trial as controls.  255 
2.6.3.3 Validation test of antimicrobial activity 256 
Validation of the agar disc diffusion assay findings was conducted quantitatively by growing 257 
the pathogen in liquid broth followed by inoculation with the selected extract. Bacterial 258 
strains (from 2.6.3.1) were diluted 1/50 in LB/marine LB broth and 180 μL of the broth and 259 
cell mix were subsequently pipetted into a well on a 96 well plate. Extract (20 μL) was added 260 
and the plates were incubated for 24 h at 30°C. Absorbance was measured at 600 nm using a 261 
14 
 
plate reader and absorbance values were compared against the absorbance of wells containing 262 
only LB/marine LB broth.  263 
2.7 Bioethanol production from the bio-refinery process residue 264 
2.7.1 Pre-treatment of the remaining residue 265 
Processed L. digitata residue was subjected to a 1.5N sulphuric acid pre-treatment and an 266 
entirely water-based auto-hydrolytical pre-treatment, both at a 25% (w/v) biomass to reactant 267 
loading rate for 24 min at 121°C in a bench top autoclave. These protocols were previously 268 
determined to be optimal for seaweed biomass (unpublished data). Residues after pre-269 
treatment were recovered and evaluated for pre-treatment efficacy by mixing subsamples (0.1 270 
g) of the dried pre-treated seaweed residues with 20 mL of 50 mM sodium citrate buffer (pH 271 
5) and dosed with an excess of Novozymes Cellic® CTec2 (ca. 50 FPU/g biomass). An 272 
enzyme hydrolysis was also performed directly on 0.1 g of processed L. digitata residue 273 
(without any prior pre-treatment), also with an excess of Novozymes Cellic® CTec2 (ca. 50 274 
FPU/g biomass) in 20 mL of 50 mM sodium citrate buffer. Samples were then incubated at 275 
50°C for 48 h in a shaking incubator set at 120 rpm. Amounts of glucose present in the 276 
enzyme hydrolysate were quantified by HPAEC-PAD (Section 2.8) and calculated as the 277 
amount (mg) liberated from 1 g of dried pre-treated/non-pre-treated seaweed residue. 278 
Achieved percentage theoretical yields of glucose were determined by the following 279 
equation: 280 
𝐴𝑐ℎ𝑖𝑒𝑣𝑒𝑑 % 𝑇ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 =  
𝐺𝑙𝑢𝑐𝑜𝑠𝑒 𝑟𝑒𝑙𝑒𝑎𝑠𝑒𝑑 𝑓𝑟𝑜𝑚 𝑝𝑟𝑒𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑎𝑛𝑑 𝑒𝑛𝑧𝑦𝑚𝑎𝑡𝑖𝑐 ℎ𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑖𝑠 𝑜𝑛 𝑟𝑒𝑠𝑖𝑑𝑢𝑒
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 𝑝𝑟𝑒𝑠𝑒𝑛𝑡 𝑖𝑛 𝑛𝑎𝑡𝑖𝑣𝑒 𝐿. 𝑑𝑖𝑔𝑖𝑡𝑎𝑡𝑎 
  × 100 
Higher glucose yields obtained from the enzymatic saccharification were indicative of a more 281 
effective pre-treatment. All experiments were conducted in triplicate. 282 
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2.7.2 Laboratory scale trial fermentations of residue hydrolysates for bioethanol 283 
production 284 
Hydrolysates (generated after enzyme saccharification and described in section 2.7.1) were 285 
fermented using S. cerevisiae strain NCYC 2592 following the method described in Kostas et 286 
al (28). Final glucose and ethanol yields were quantified by HPAEC-PAD and HPLC (section 287 
2.8). All trials were conducted in triplicate. 288 
2.8 Quantification of monosaccharides (HPAEC-PAD) and ethanol (HPLC) 289 
The monosaccharide concentrations were quantified using Dionex ICS-3000 Reagent-Free 290 
Ion Chromatography, electrochemical detection using ED 40 and computer controller.  A 291 
CarboPacTM PA 20 column (3×150 mm) was used, with a mobile phase of 10 mM NaOH at 292 
an isocratic flow rate of 0.5 mL/min. The injection volume was 10 μL and the column 293 
temperature was maintained at 30°C. Authentic standards of monosaccharides (mannitol, 294 
fucose, arabinose, galactose, glucose and xylose) were used to generate calibration curves 295 
(0.0625-1 g/L) for monosaccharide quantification. 296 
Ethanol yields were quantified by HPLC following the method outlined in Wilkinson et al 297 
(29). Prior to HPLC analysis, all samples and standards were filtered using Whatman GD/X 298 
syringe filters (GF/C 25 mm filter diameter/1.2 μm pore size; Whatman, UK). All 299 
experiments were conducted in triplicate. 300 
3 Results and Discussion 301 
3.1 Extraction of fucoidan and alginate from L. digitata  302 
A total of 130.9 mg fucoidan with a measured purity of 65% and 98.4 mg alginate were 303 
extracted from 2 g of L. digitata (Table 2. 304 
 305 
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L. digitata IN  2 g  
L. digitata OUT (residue weight)  1.54 g ± 0.02  
Alginate  98.4 mg ± 0.1  
Fucoidan (crude)  130.9 mg ± 1.1  
Fucoidan Purity  65 % ± 2.1  
Fucoidan Sulphate Content 
Process losses 
 23.8 % ± 1.6 
230.7 mg 
 
 
Fucoidan Monosaccharide Profile 
   
Arabinose  4.6 % ± 0.3  
Galactose  17.0 % ± 0.5  
Glucose  30.9 % ± 1.5  
Fucose  42.5 % ± 2.2  
Xylose  2.6 % ± 0.1  
 306 
Table 2 Product yields and losses generated from the extraction of fucoidan and alginate 307 
from L. digitata, including fucoidan purity, fucoidan sulphate content and fucoidan 308 
monosaccharide profile. 309 
From the 2 g of L. digitata used in the process, only 1.54 g was recovered after the extraction. 310 
Therefore approximately 460 mg of material was solubilised from the starting material. The 311 
main products from the extraction process (fucoidan and alginate) together yielded a total of 312 
229.3 mg, leaving approximately 230.7 mg of material unaccounted for. This group of 313 
unaccounted for material has been termed ‘process losses’ and represents other extracted 314 
components of the biomass which had not been precipitated/ recovered. Other extracted 315 
materials from the seaweed such as pigments, polysaccharides/monosaccharides, proteins, 316 
polyphenols, minerals and salts would have comprised this solubilised matter. Furthermore, 317 
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products from the extraction process could have been volatilised during the first stage of the 318 
extraction process, in which the contents of the reaction was heated to 70°C. 319 
The fucoidan extract was predominantly composed of fucose followed by a significant 320 
proportion of glucose and galactose, and minor amounts of arabinose and xylose. This is in 321 
agreement with published literature which describes fucoidan as being extremely 322 
heterogeneous with a branched structure (30). Besides monosaccharide content, the sulphate 323 
content was determined to be 23.8% and is in broad agreement with values previously 324 
reported (27). Reports have suggested that the fucoidan content of brown seaweeds is 325 
typically around 10% (d/w) however this value may vary according to the species of 326 
seaweed, within species population, harvesting season, region of isolation and even 327 
environmental temperature (31-33). Based on this assumption, it was estimated that the 328 
overall extraction efficiency was around 65.4 %, as such there is room for further 329 
optimisation of the extraction process to enhance fucoidan extract yields. Interest in fucoidan 330 
has increased in recent years, particularly since the polysaccharide has been shown to exhibit 331 
a number of pharmaceutically interesting biological activities such as anti-cancer (34), anti-332 
inflammatory (35) and anti-viral (36) properties; making it desirable for extraction. The 333 
seasonal variations in seaweed polysaccharide contents have often been a hindrance and a 334 
factor which has held back the sustainable development of bio-refinery processes that are 335 
based purely on speciality polysaccharide extraction. Bruhn et al (32) found that the crude 336 
fucoidan content and potential harvest yields in studies performed with North Atlantic 337 
Saccharina latissima and L. digitata varied by a factor of 2-2.6 over 1 year. The study also 338 
found that different seasonal peaks of fucoidan exist between populations of the same 339 
species; thus making it difficult to identify a general recommended harvesting time. 340 
However, annual fluctuation in the levels of fucoidan from various Fucoid species was 341 
recently determined by Fletcher et al  (37) who identified that whilst the best time to harvest 342 
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(in terms of maximum fucoidan content) is late autumn/early winter, the actual range of 343 
fucoidan content (minimum and maximum) was relatively small. From an industrial 344 
processing perspective this is significant, since it would potentially facilitate more consistent 345 
recovery of the fucoidan polysaccharide. Therefore, the selection of a suitable brown species 346 
of seaweed is imperative in the design of cascading bio-refineries. Furthermore, year-round 347 
use of that particular species would eliminate the requirements for drying and storage, 348 
reducing overall processing costs and enhance life cycle analysis/techno-economical 349 
assessment of the bio-process.  350 
3.2 Evaluation of the waste residue after fucoidan and alginate extraction 351 
The composition of the waste residue following extraction can be seen in Table 3 along with 352 
the original composition of L. digitata seaweed for comparison.  353 
Composition (d/w %) Native Seaweed Residue following 
alginate and 
fucoidan extraction 
Moisture 8.0 4.4 
Protein 12.9 14.1 
Ash 26.0 23.4 
Lipid 1.0 0.9 
Crude Fibre 5.5 15.5 
Carbohydrate 46.6 41.4 
 354 
Table 3 Proximate composition of L. digitata before and after the extraction of alginate and 355 
fucoidan 356 
The ash decreased from a content of 26.0% (d/w) to 23.4% (d/w) and protein content 357 
increased from 12.9 to 14% (d/w); suggesting a slight enrichment of the protein fraction and 358 
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highlighting a potential protein-based product stream that would be worth evaluating for 359 
added value to the bio-refinery. Although there appeared to be a reduction in the 360 
carbohydrate content, from 46.6% to 41.4% (d/w), which most likely resulted from the 361 
extraction of alginate and fucoidan, there was an increase in crude fibre content from 5.5% to 362 
15.5% (d/w), respectively. The authors consider that this may be the consequence of an 363 
enriched cellulose fraction. When investigating the monosaccharide profile of the seaweed 364 
residue, it became apparent that the predominant monosaccharide was glucose (161.9 mg/g of 365 
residue; Fig 2).  366 
  367 
Fig 2 Monosaccharide composition of the waste residue following extraction of alginate and 368 
fucoidan from L. digitata 369 
This of course represented a promising substrate for the subsequent production of bioethanol 370 
due to the high glucose content. However, a small fraction of fucose (16.7 mg/g) was 371 
additionally detected, suggesting that not all of the fucoidan was extracted from the L. 372 
digitata during the previous extraction process step and confirmed the requirement of further 373 
adjustments (optimisation) to maximise recovery of fucoidan. In addition, uronic acids such 374 
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as mannuronic and guluronic acids may have also been released (in the case that not all of the 375 
alginate was extracted) but were not quantified using the analytical method applied.  376 
3.3 Bioethanol production from the waste residue 377 
3.3.1 Pre-treatment and enzymatic saccharification of new residue 378 
The pre-treatment stage for bioethanol production from the remaining waste residue was not 379 
optimised in this study. However optimum pre-treatment conditions for native L. digitata 380 
seaweed biomass that were previously developed by the authors (unpublished data) were 381 
applied as a starting point for the deconstruction of the remaining material in this study. The 382 
solubilised yields of glucose can be seen in Fig 3. 383 
Fig 3 Liberation of glucose after enzymatic saccharification of the waste residue. Data are the 384 
mean ± SD of three replicates 385 
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Ctec: direct enzyme hydrolysis on waste residue with an excess of Novozymes Cellic® CTec2 (ca 50 FPU/g 386 
biomass) Sulphuric acid treatment + Ctec2: 1.5 N H2S04, 25% (w/v) biomass to reactant loading rate for 24 387 
min at 121°C in a benchtop autoclave followed by enzymatic hydrolysis with an excess of Novozymes Cellic® 388 
CTec2 (ca 50 FPU/g biomass). Water treatment + Ctec2: Auto-hydrolytical (entirely water based) pre-389 
treatment at 25% (w/v) biomass to reactant loading rate for 24 min at 121°C in a benchtop autoclave followed 390 
by enzymatic hydrolysis with an excess of Novozymes Cellic® CTec2 (ca 50 FPU/g biomass). 391 
 392 
Almost 50% theoretical yield of glucose resulted from the direct saccharification (with an 393 
excess of Novozymes Cellic® CTec2) of the remaining waste residue without any prior pre-394 
treatment. Pre-treating the residue with sulphuric acid liberated the greatest amount of 395 
glucose (151.8 mg/g), achieving 93.8% theoretical yield of glucose following enzyme 396 
hydrolysis. In contrast, the auto-hydrolytically (water-based) pre-treated residue liberated 397 
118.2 mg/g glucose after enzyme saccharification which corresponded to a 73.2% theoretical 398 
yield of glucose. Overall, it appeared that a dilute form of acid pre-treatment was still 399 
required to achieve the maximal solubilisation of glucose from this material. This suggests that 400 
the waste residue still contained recalcitrant and unexposed substrate specific surface areas, thus 401 
reducing access for the cellulolytic enzymes to target. However with further optimisation, it may 402 
be possible to enhance the overall yields of glucose with the application of an entirely water-403 
based pre-treatment. This would essentially make the overall bio-process more 404 
environmentally friendly (avoiding the need to use acid reagents, to remove salts formed 405 
from subsequent neutralisation and having to potentially discard any acid ‘waste’ produced) 406 
and reduce the overall operation costs of the process.  407 
3.3.2 Bioethanol production 408 
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The fermentation progression and ethanol yield data using S. cerevisiae NCYC2592 are 409 
shown in Fig 4 A and B.  410 
  411 
Fig 4 Ethanol yield data (A) and fermentation progression (B) for fermentation with S. 412 
cerevisiae strain NCYC2592 of the hydrolysate produced from the remaining seaweed 413 
residue after fucoidan/alginate extraction. Data are the mean ± SD of three replicates. 414 
A: Theoretical ethanol yield based on based on mean glucose concentration in the three feedstocks. B: 415 
Fermentation progression monitored by weight-loss of vessels due to CO2 evolution  416 
 417 
A yield of 3.0 g/L of ethanol was produced from the fermentation of the hydrolysate 418 
generated from the new composite which equated to ca 94.4% of theoretical ethanol yield 419 
(calculated from the initial content of glucose present in the hydrolysate). Although the total 420 
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volumetric yield of ethanol produced from the hydrolysate was low (0.3% ABV), ethanol 421 
production from this hydrolysate was not fully optimised for other sugars that may be present 422 
such as galactose and xylose. Given that an apparent 94.4% theoretical ethanol yield (from 423 
glucose) was achieved from fermentation, it appeared that the ethanol titre could only be 424 
significantly improved in the present process by increasing the concentration of sugars 425 
present in the hydrolysate prior to fermentation. This may certainly be possible once pre-426 
treatment and enzyme hydrolysis conditions on the new seaweed residue have been 427 
optimised.  428 
3.4 Bioactivity analysis of process products/waste streams 429 
3.4.1 Antioxidant activity 430 
As seen in Fig 5, both assays (DPPH
●
 and ABTS
●+
)
 
revealed comparable antioxidant activity 431 
levels across all extracts investigated.  432 
 433 
Fig 5 Antioxidant activities (DPPH
●
 and ABTS
●+
)
 
of bio-refinery process extracts. Extract 434 
(and solvent) and corresponding extract codes: Waste liquor (methanol) - WL-M; Fucoidan 435 
extract (water) - FE-W; Fucoidan standard (water) - FS-W; L. digitata (methanol) - LD-M; 436 
Waste Residue (methanol) - WR-M; Waste Residue (water) - WR-W; L. digitata (water) - 437 
LD-W.  438 
The fucoidan extract from the bio-refining process had a DPPH
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 inhibition value of 76.0% ± 439 
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fucoidan standard. This could be due to the fact that the fucoidan standard is of a higher 441 
purity than the extracted fucoidan. Studies have suggested that the scavenging effect of the 442 
fucoidan polysaccharide may result from the presence of the sulphate group positioned at O-2 443 
which is close to the glycosidic bond (38). In contrast to the DPPH
● 
assay, the extracted 444 
fucoidan was not able to interact with the ABTS
●+ 
radical and therefore a colour change was 445 
not detected. The DPPH
● 
scavenging ability of native L. digitata (water extract) had an 446 
inhibition value of 46.5% ± 10.4, whereas inhibition values of the waste residue extract 447 
(water extract) were lower (27.9% ± 2.6). Values obtained from the ABTS
●+ 
assay was 12.7% 448 
± 0.5. A cause of these lower values may have been the prior extraction of the fucoidan 449 
polysaccharide which itself has been shown to have substantial antioxidant capacity (39). 450 
Additionally, other compounds present in the native L. digitata that possess antioxidant 451 
properties (e.g. phenolic compounds (40)) could have likewise been removed during the 452 
extraction process. The DPPH
● 
assay revealed the waste liquor from the process to have an 453 
inhibition value of 65.05% ± 3.2 (for the methanol extract). In order to put the DPPH 454 
antioxidant values of the extracts produced from the bio-refining process into perspective, 455 
EC50 values of the samples were calculated and compared against a known antioxidant 456 
(ascorbic acid) and also other extracts of fucoidan obtained from the literature (Table 4).   457 
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 459 
 460 
 461 
 462 
 463 
 464 
Table 4 Comparison of DPPH antioxidant inhibition activity (%) of the extracts produced from the bio-refining process compared against the 465 
reference compound ascorbic acid and also extracts of fucoidan from other studies.  466 
EC50 values for the DPPH
●
 radical scavenging activity are also included as a means to compare antioxidant capacities.* EC50 denoted as the concentration of sample required 467 
to scavenge 50% DPPH radicals (lower the value, the higher the antioxidant capacity).  468 
 469 
 470 
 471 
Compound/Extract DPPH Inhibition (%) Concentration (mg/mL) DPPH *EC50 (mg/mL) Reference 
Ascorbic acid 95.6 3.0 1.6 (41) 
Fucoidan extract from L. digitata 76.0 20.0 13.2 Present study 
Native L. digitata extract (water) 46.5 20.0 21.5 Present study 
L. digitata residue (water) 27.9 20.0 35.8 Present study 
Waste liquor extract (methanol) 65.1 20.0 15.3 Present study 
Fucoidan from A. nodosum 30.4 10.0 16.5 (41) 
Fucoidan from S. vulgare 22.0 3.0 6.8 (42) 
Fucoidan from S. pallidum 19.1 3.8 10.0 (43) 
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The fucoidan extract from the bio-refining process (with an EC50 value of 13.2 mg/mL) was 472 
within the same range of activity as fucoidan extracted from alternative species of 473 
Ascophyllum nodosum (16.5 mg/mL; (41)) and Sargassum pallidum (10.0 mg/mL; (43). In 474 
contrast fucoidan extracted from S. vulgare exhibited stronger DPPH radical scavenging 475 
abilities than the fucoidan extracts from the literature, as only 6.8 mg/mL of the extract is 476 
required to scavenge 50% DPPH radicals (42); confirming that levels may be influenced by 477 
fucoidan source of origin.  Interestingly, the waste liquor extract from the bio-process 478 
exhibited an EC50 value that was in a similar range with the fucoidan extract (15.3 mg/mL 479 
and 13.2 mg/mL, respectively). This highlights an opportunity for another potential stream of 480 
added value from the putative process. It is speculated that algal polyphenols (including 481 
tannins and flavonoids) are the principal constituents responsible for the antioxidant 482 
properties of the waste liquor from the process; this is certainly worth further investigation by 483 
way of developing a potential application in either the health and/or nutraceuticals industries. 484 
3.4.2 Antimicrobial activity 485 
Eleven different bacterial strains, ranging from common food pathogenic bacteria, food 486 
spoilage bacteria and fish pathogenic bacteria were investigated in this study to identify 487 
whether any of the generated extracts from the bio-process could inhibit their growth. A 488 
summary of the positive pathogen and extract combination results (specific combinations that 489 
produced clearance zones indicating inhibition) can be seen in Tables 5A+B. 490 
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 491 
 492 
 493 
 494 
 495 
 496 
 497 
 498 
Table 5 (A) Summary of extracts that produced clearance zones (inhibition of pathogen growth) on the standard agar disc diffusion assay and 499 
(B) growth inhibition after 24 h of selected process extracts against selected human pathogenic
(a)
, food spoilage
(b)
 and fish pathogenic
(c)
 bacteria. 500 
Extract Extract Code Pathogen growth inhibition 
Waste liquor (methanol) WL-M S. enterica, B. cenocepacia, B. cereus 
Fucoidan extract (water) FE-W B. cenocepacia, S. enterica 
Fucoidan standard (water) FS-W S. pyogenes, L. monocytogenes, V. anguillerium 
L. digitata (methanol) LD-M B. cenocepacia 
Waste Residue (methanol) WR-M B. cenocepacia 
Waste Residue (water) WR-W V. anguillerium, Y. ruckerii,  
L. digitata (water) LD-W A. iwofii, A. hydrolphila, V. anguillerium 
    ABS at 600 nm 
 
Broth & Cells + Extract (ABS at 600 nm) 
  0 h  24 h 
Strain Name   Broth&Cells 
 
WL-M FE-W WR-W LD-M FS-W LD-W WR-M 
Salmonella enterica
a 
 
1.13±0.05 
 
1.15±0.29 1.21±0.99 - - - - - 
Burkholderia cenocepacia
a 
 
1.21±0.14 
 
1.06±0.19 1.24±0.32 - 1.17±0.59 - - 1.10±0.06 
Burkholderia multivorans
a 
 
1.10±0.52 
 
- - 1.02±0.06 - - - - 
Bacillus cereus
b 
 
1.08±0.23 
 
1.02±0.32 - - 1.03±0.09 - - - 
Streptococcus pyogenes
a 
 
0.73±0.85 
 
- - - - 0.94±0.36 - - 
Acinetobacter iwofii
a 
 
1.23±0.03 
 
- - - - - 1.30±0.36 - 
Listeria monocytogenes
a 
 
1.04±0.56 
 
- - - - 1.21±0.12 - - 
Yersinia ruckerii
c 
 
0.55±0.36 
 
- - 0.54±0.09 - - - - 
Vibrio anguillerium
c 
 
0.73±0.25 
 
- - 0.76±0.19 - 0.79±0.32 0.74±0.09 - 
Aeromonas hydrolphila
c 
  0.85±0.16 
 
- - - - - 1.00±0.04 - 
A 
B 
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Experiments were performed in triplicate and each value is presented as mean ± SD. Waste liquor (methanol) - WL-M; Fucoidan extract (water) 501 
- FE-W; Fucoidan standard (water) - FS-W; L. digitata (methanol) - LD-M; Waste Residue (methanol) - WR-M; Waste Residue (water) - WR-502 
W; L. digitata (water) - LD-W.  503 
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Inhibition of pathogenic bacterial growth was confirmed for three out of the 10 selected 504 
pathogenic strains. Growth of B. cenocepacia, originally known as a plant pathogen which 505 
has now emerged as a life-threatening multi-resistant pathogen in cystic fibrosis patients (44), 506 
appeared to be inhibited by extracts prepared from the process waste liquor and both native 507 
and residue L. digitata extracts (methanol extracts). Absorbance readings after 24 h of growth 508 
appeared to be lower than the reading at 0 h therefore suggesting inhibition; the 0 h 509 
absorbance reading at 600 nm was 1.21 however after 24 h absorbance values were 1.06, 1.17 510 
and 1.10 for the waste liquor, native L. digitata and residue L. digitata extracts, respectively. 511 
Likewise, B. multivorans growth was supressed after 24 h incubation with the L. digitata 512 
residue extract, as was B. cereus; however the waste liquor extract additionally inhibited B. 513 
cereus growth in the liquid media. It has been documented that Burkholderia bacteria are 514 
resistant to a number of clinically used antimicrobial agents, such as polymyxins and 515 
aminoglycosidases (45) and there is an increasing need to identify novel antimicrobial 516 
compounds for activity against Burkholderia species (46). Research on natural antimicrobial 517 
compound isolation from medicinal plants however is looking promising and extracts 518 
prepared from Echinacea purpunea (47) and allicin-containing garlic extracts (48) have 519 
shown antimicrobial effects. However, this is the first study to show antimicrobial inhibition 520 
from extracts prepared from a L. digitata bio-process. It appeared that the inhibition of 521 
pathogenic growth was selective to certain strains and extracts in a liquid medium, and not all 522 
of the combinations that had been identified from the agar disc diffusion assay displayed 523 
inhibitory activity. The reasons behind this are unclear; however the agar disc diffusion assay 524 
did serve as an effective and rapid screening tool. Additionally it appeared that methanol was 525 
a suitable solvent for the extraction of functional antimicrobials from process products, and 526 
further research is needed to validate these findings.  527 
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4 Conclusion 528 
The research presented in this study described the development of a feasible seaweed bio-529 
refining process based on the abundant UK brown seaweed L. digitata. Overall, this study 530 
demonstrated that there is great potential for further exploratory work with regards further 531 
development of this particular bio-refinery process. Two valuable brown seaweed 532 
polysaccharides were extracted, one of which displayed interesting biological activities. 533 
Bioethanol was then successfully produced from the residue which remained after the 534 
extraction. In addition, extracts that were generated from various streams of the process 535 
(including the waste streams) displayed antimicrobial and antioxidant activities. As such, 536 
characterisation of the extracts to specifically identify the bioactive compounds would be of 537 
great interest to further develop this process. 538 
While this study identifies significant pathways to enable the development of a L. digitata-539 
based bio-refinery, there is still much more research that is required to optimise and enhance 540 
the overall process efficiency. In particular, the ethanol yields in the present study were too 541 
low (3 g/L) to be economically viable on a commercial scale. Furthermore, the identification 542 
of other valuable by-products with interesting bioactivities or the screening for potential 543 
platform chemicals in waste streams may also contribute to the development of a cost 544 
efficient bio-refining process for L. digitata.  545 
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